A director at Umicore S.A. sold 2,739 shares at 17.990EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Azelis: 1Q26 Adj. EBITA beats by 6%, APAC returns to growth and solid FCF. BE Semiconductor Industries: 1Q26 results, solid Hybrid Bonding orders. Fugro: 1Q26: Optimism not yet justified. Gecina: Open to share buybacks. Heineken: So long, Dolf. Kinepolis: Strong 1Q26 visitors, good start to 2Q, country mix disappoints. MICC: Consensus publication for 1Q26. Ontex: Peer Essity 1Q26 results. RELX: 1Q26 trading update – outlook reiterated, execution on track
Transparency Declaration Notification Regulated information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholding by the Goldman Sachs Group, Inc. On April 15, 2026, Ontex received a transparency declaration confirming that, on April 10, 2026, the Goldman Sachs Group, Inc., detained 116,325 Ontex voting rights and 2,461,101 equivalent financial instruments or 2,577,426 in total, representing respectively 0.14%, 2...
Kennisgeving transparantieverklaring Gereglementeerde informatie In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex Group NV (“Ontex”) de verklaringen van belangrijke deelnemingen door Goldman Sachs Group, Inc. bekend. Op 15 april 2026 ontving de Vennootschap een transparantieverklaring waarin werd bevestigd dat Goldman Sachs Group Inc. op 10 april 2026 116.325 stemrechten van Ontex bezat en 2.461.101 equivalente financiële instrumenten, ofwel 2.577.426 in totaal. Dit vertege...
UCB announced that it has entered into a definitive agreement to acquire Neurona Therapeutics, including lead epilepsy cell therapy asset NRTX-1001, for a $ 650m upfront and up to $ 500m in potential milestones. We're encouraged by NRTX-1001's phase 1/2 data showing approx. 80% reduction in disabling seizures at 4-6 months post administration in drug-resistant unilateral mesial temporal lobe epilepsy (MTLE), with or without mesial temporal sclerosis (MTS), and look forward to the phase 3 progra...
UCB presented new global, real-world, patient-centric data that highlighted quality of life impacts for epilepsy patients and caregivers at the American Academy of Neurology (AAN) conference, being held 18-22 April. The data shows the impact of sleep disturbances on activities of daily living (ADL) and communication, the negative impact of prolonged seizures on daily activities including work productivity, and the benefit of treatment persistence with Fintepla, which led to reduced healthcare re...
Raw materials inflation is back on the agenda with polypropylene and polyethylene up c. 30% YTD. The previous raw materials inflation cycles have learned that Ontex cannot pass such a sizable inflation swiftly to its customers but will need at least a few quarters to do so. We believe the FY26 guidance of 10% adjusted EBITDA growth is no longer achievable and have lowered our forecasts to now include a 3% y/y drop. Lowered forecasts also imply that the headroom vs debt covenants is shrinking, al...
Ontex announces details for its Q1 2026 results publication Aalst, Belgium, April 13, 2026 – Ontex Group NV, a leading international developer and producer of personal care products, will share its results for the first quarter of 2026 at 07:00 CEST / 06:00 BST on Wednesday, April 29, 2026. Management will host a webcast for investors and analysts on the same day at 12:00 CEST / 11:00 BST. Click on the following link to attend the presentation: /26q1_results_call. A replay of the webcast will be available on the same link shortly after the conclusion of the live presentation, and remain so ...
Ontex kondigt details aan voor de resultatenpublicatie van het 1ste kwartaal van 2026 Aalst, België, 13 april 2026 – Ontex Group NV, een toonaangevende internationale ontwikkelaar en producent van persoonlijke verzorgingsproducten, zal zijn resultaten van het eerste kwartaal van 2026 delen om 07:00 uur CEST op woensdag 29 april 2026. Het directiecomité zal op dezelfde dag een Engelstalige webcast voor investeerders en analisten opzetten om 12:00 uur CEST. Klik op de volgende link om de presentatie bij te wonen vanop uw laptop, tablet of mobiel apparaat: . Een herhaling van de webcast zal ko...
Publication of the 2025 annual report and convening notice for the Ordinary and Extraordinary General Meeting Publication of the 2025 annual report and convening notice for the Ordinary and Extraordinary General Meeting Regulated information 10 April 2026, 8 a.m. CET Kinepolis Group NV presents its integrated annual report 2025, with a comprehensive overview of the Group's strategic, financial, operational and ESG performance for the year 2025. The report is available in English and Dutch and can be accessed Kinepolis' annual report 2025 includes a sustainability statement prepared in...
Publication du rapport annuel 2025 et convocation à l’Assemblée générale ordinaire et extraordinaire Publication du rapport annuel 2025 et convocation à l’Assemblée générale ordinaire et extraordinaire Information réglementée 10 avril 2026, 8h00 CET Kinepolis Group SA présente son rapport annuel intégré 2025, avec un aperçu complet des performances stratégiques, financières, opérationnelles et ESG du Groupe pour l'année 2025. Le rapport est disponible en anglais et en néerlandais et peut être consulté Le rapport annuel 2025 de Kinepolis intègre un rapport de durabilité préparé conform...
Publicatie jaarverslag 2025 en oproeping Gewone en Buitengewone Algemene Vergadering Publicatie jaarverslag 2025 en oproeping Gewone en Buitengewone Algemene Vergadering Gereglementeerd bericht 10 april 2026, 8u00 CET Kinepolis Group NV presenteert haar geïntegreerd jaarverslag 2025, met een uitgebreid overzicht van de strategische, financiële, operationele en ESG-prestaties van de Groep over het jaar 2025. Het verslag is beschikbaar in het Engels en Nederlands en kan worden geraadpleegd Kinepolis’ jaarverslag 2025 bevat een duurzaamheidsverslag opgesteld in ov...
We downgrade the stock from Buy to HOLD and lower our target price from €195.00 to €182.25 expecting earnings momentum to turn negative in 2027-28F. DEME reported better-than-expected 2H25 results and provided a 2026 outlook that exceeded our expectations. This coincided with EU politicians stepping up their commitments to install more MW offshore wind energy towards 2029-30. Looking at the supply chain, we see early cyclical offshore wind players struggling with low order intake and low activit...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.